Immatics N.V. (IMTX) Form 10-Q Quarterly Reports
Immatics N.V. (IMTX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IMTX
CIK: 1809196
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: P7
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerMarcus Nickel
Audit LocationStuttgart, Germany
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-08-27 | 2026-08-26 | 4 | 0001193125-26-371237 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-27 | — | SCHEDULE 13D/A Filing | 0001193125-26-371236 | View SEC Doc Filr Page |
| 6-K | 2026-08-26 | 2026-08-26 | 6-K | 0001193125-26-368946 | View SEC Doc Filr Page |
| 424B2 | 2026-08-25 | — | 424B2 | 0001193125-26-365394 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | FORM 4 | 0000950103-26-012582 | View SEC Doc Filr Page |
| 6-K | 2026-08-18 | 2026-06-30 | 6-K | 0001193125-26-354715 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097045 | View SEC Doc Filr Page |
| 3 | 2026-07-29 | 2026-07-20 | 3 Filing | 0000950103-26-011324 | View SEC Doc Filr Page |
| S-8 | 2026-06-25 | — | FORM S-8 | 0000950103-26-009506 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | FORM 4 | 0000950103-26-009251 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | FORM 4 | 0000950103-26-009244 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | FORM 4 | 0000950103-26-009243 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | FORM 4 | 0000950103-26-009242 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | FORM 4 | 0000950103-26-009241 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | FORM 4 | 0000950103-26-009239 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | FORM 4 | 0000950103-26-009235 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001193125-26-275960 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | FORM 4 | 0000950103-26-009234 | View SEC Doc Filr Page |
| 6-K | 2026-06-18 | 2026-06-18 | FORM 6-K | 0000950103-26-009230 | View SEC Doc Filr Page |
| 6-K | 2026-06-02 | 2026-06-02 | FORM 6-K | 0000950103-26-008259 | View SEC Doc Filr Page |
| 6-K | 2026-06-01 | 2026-06-01 | FORM 6-K | 0000950103-26-008113 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000902664-26-002549 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0000947263-26-000045 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001897612-26-000498 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001493215-26-000108 | View SEC Doc Filr Page |